{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-009682","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.642345+00:00","generated_at":"2026-05-15T14:42:02.327800+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Oragenics gets HREC approval, starts Phase IIa site activation for ONP-002 in Australia; explores CNS asset acquisition","bullets":["Received final HREC approval in Australia for Phase IIa trial of ONP-002 for concussion/mTBI.","Completed first site initiation visit (SIV) for Phase IIa trial; two more sites in final RGO review.","Phase IIa trial of 40 patients; first dose within 12 hours of injury; data readout expected before year-end 2026.","Exploring discussions with third parties for potential acquisition of CNS assets focusing on brain health/recovery.","No definitive agreements reached; platform expansion independent of Receptor.AI partnership."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-009682","json":"https://secwatch.observer/filing/0001493152-26-009682.json","markdown":"https://secwatch.observer/filing/0001493152-26-009682.md","text":"https://secwatch.observer/filing/0001493152-26-009682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315226009682/0001493152-26-009682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315226009682/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:42:02.327800+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}